Tom Clancy's The Division Resurgence has been launched globally for Android and iOS users, bringing its popular shooter franchise to mobile with a new storyline, co-op gameplay, and more ...

Master Claude Code in 2026 with this complete guide to built-in sub-agents, operator patterns, and headless mode for ...

Progress has released patches for multiple remote code execution and OS command injection flaws in MOVEit WAF and LoadMaster.

The Microsoft Defender Security Research Team has confirmed that a pervasive new authentication code attack is compromising hundreds of organizations daily.

Embark on a gaming journey with Garena Free Fire MAX, a title that has become a staple in the Indian gaming community, especially after the ban of its predecessor. This battle royale game, known for ...

Garena Free Fire MAX offers a battle royale experience with upgraded graphics and effects, and players now get fresh redeem codes for 8 April 2026. These codes allow players in India and elsewhere to ...

The more than 512,000 lines of leaked code appear to show unreleased features, instructions for Claude, and more. The more than 512,000 lines of leaked code appear to show unreleased features, ...

VentureBeat made with Google Gemini 3.1 Pro Image Anthropic appears to have accidentally revealed the inner workings of one of its most popular and lucrative AI products, the agentic AI harness Claude ...

Ubisoft's third-person looter shooter, The Division Resurgence, is finally available on Android and iOS, offering players a brand-new canonical story set in the same universe as The Division and The ...

Cursor announced Thursday the launch of Cursor 3, a new product interface that allows users to spin up AI coding agents to complete tasks on their behalf. The product, which was developed under the ...

The order gives President Trump more military options as he considers diplomacy with Iran. It is unclear where the soldiers will go in the Middle East. By Eric Schmitt Reporting from Washington The ...

The UK regulatory authority has cleared the path for some patients with generalised myasthenia gravis (gMG) to get early access to Argenx' efgartigimod while it reviews the marketing application for ...